Literature DB >> 20051853

Essential hypertension and risk of nephropathy: a reappraisal.

Mariana Murea1, Barry I Freedman.   

Abstract

PURPOSE OF REVIEW: Treating mild-to-moderate essential hypertension in nondiabetic African Americans fails to halt nephropathy progression, whereas hypertension control slows nephropathy progression in European Americans. The pathogenesis of these disparate renal syndromes is reviewed. RECENT
FINDINGS: The nonmuscle myosin heavy chain 9 gene (MYH9) is associated with a spectrum of kidney diseases in African Americans, including idiopathic focal global glomerulosclerosis historically attributed to hypertension, idiopathic focal segmental glomerulosclerosis, and the collapsing variant of focal segmental glomerulosclerosis [HIV-associated nephropathy (HIVAN)]. Risk variants in MYH9 likely contribute to the failure of hypertension control to slow progressive kidney disease in nondiabetic African Americans.
SUMMARY: Early and intensive hypertension control fails to halt progression of 'hypertensive nephropathy' in African Americans. Genetic analyses in patients with essential hypertension and nephropathy attributed to hypertension, focal segmental glomerulosclerosis and HIVAN reveal that MYH9 gene polymorphisms are associated with a spectrum of kidney diseases in this ethnic group. Mild to moderate hypertension may cause nephropathy in European Americans with intrarenal vascular disease improved by the treatment of hypertension, hyperlipidemia and smoking cessation.

Entities:  

Mesh:

Year:  2010        PMID: 20051853      PMCID: PMC2904692          DOI: 10.1097/MNH.0b013e3283366344

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  68 in total

1.  End-stage renal disease in two pediatric patients with Fechtner syndrome.

Authors:  M M Moxey-Mims; G Young; A Silverman; D M Selby; J G White; K K Kher
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

2.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Comeau; Jasmin Divers; Anthony J Bleyer; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2009-06-30       Impact factor: 5.992

4.  Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.

Authors:  Amber M Reeves-Daniel; Samy S Iskandar; Donald W Bowden; Meredith A Bostrom; Pamela J Hicks; Mary E Comeau; Carl D Langefeld; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2010-01-29       Impact factor: 8.860

5.  Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.

Authors:  Joel M Henderson; Mariam P Alexander; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

6.  Genome-wide linkage analysis of serum creatinine in three isolated European populations.

Authors:  Cristian Pattaro; Yurii S Aulchenko; Aaron Isaacs; Veronique Vitart; Caroline Hayward; Christopher S Franklin; Ozren Polasek; Ivana Kolcic; Zrinka Biloglav; Susan Campbell; Nick Hastie; Gordan Lauc; Thomas Meitinger; Ben A Oostra; Ulf Gyllensten; James F Wilson; Irene Pichler; Andrew A Hicks; Harry Campbell; Alan F Wright; Igor Rudan; Cornelia M van Duijn; Peter Riegler; Fabio Marroni; Peter P Pramstaller
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

7.  Outcomes associated with race in males with nondialysis-dependent chronic kidney disease.

Authors:  Csaba P Kovesdy; John E Anderson; Stephen F Derose; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 8.237

8.  Effect of community characteristics on familial clustering of end-stage renal disease.

Authors:  Eun-Young Song; William M McClellan; Ann McClellan; Rajyalakshmi Gadi; Alexander C Hadley; Jenna Krisher; Margo Clay; Barry I Freedman
Journal:  Am J Nephrol       Date:  2009-09-30       Impact factor: 3.754

9.  Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.

Authors:  Barry I Freedman; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; D C Rao; John H Eckfeldt; Mark F Leppert; Pamela J Hicks; Jasmin Divers; Carl D Langefeld; Steven C Hunt
Journal:  Am J Nephrol       Date:  2009-01-20       Impact factor: 3.754

10.  Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Authors:  Yuqing Chen; Manjula Mahata; Fangwen Rao; Srikrishna Khandrika; Maite Courel; Maple M Fung; Kuixing Zhang; Mats Stridsberg; Michael G Ziegler; Bruce A Hamilton; Michael S Lipkowitz; Laurent Taupenot; Caroline Nievergelt; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2009-06-11       Impact factor: 10.121

View more
  12 in total

1.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

Review 2.  Renal disease in HIV-infected individuals.

Authors:  John Phair; Frank Palella
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

3.  The new era of APOL1-associated glomerulosclerosis.

Authors:  Barry I Freedman; Carl D Langefeld
Journal:  Nephrol Dial Transplant       Date:  2012-02-02       Impact factor: 5.992

4.  Risk factors: Race, renal disease and albuminuria.

Authors:  Barry I Freedman; Donald W Bowden
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 5.  Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Semin Dial       Date:  2010-05-10       Impact factor: 3.455

6.  Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.

Authors:  C P Lin; I Adrianto; C J Lessard; J A Kelly; K M Kaufman; J M Guthridge; B I Freedman; J-M Anaya; M E Alarcón-Riquelme; B A Pons-Estel; J Martin; S Glenn; A Adler; S-C Bae; S-Y Park; S-Y Bang; Y-W Song; S A Boackle; E E Brown; J C Edberg; G S Alarcón; M A Petri; L A Criswell; R Ramsey-Goldman; J D Reveille; L M Vila; G S Gilkeson; D L Kamen; J Ziegler; C O Jacob; A Rasmussen; J A James; R P Kimberly; J T Merrill; T B Niewold; R H Scofield; A M Stevens; B P Tsao; T J Vyse; C D Langefeld; K L Moser; J B Harley; P M Gaffney; C G Montgomery
Journal:  Genes Immun       Date:  2011-12-22       Impact factor: 2.676

7.  Increased circulating inflammatory endothelial cells in blacks with essential hypertension.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; John R Woollard; Sandra M Herrmann; Monika L Gloviczki; Ahmed Saad; Luis A Juncos; David A Calhoun; Andrew D Rule; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2013-06-24       Impact factor: 10.190

Review 8.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

9.  Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Lingyi Lu; Jasmin Divers; Mary E Comeau; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Randall C Johnson; Nicholette D Palmer; Pamela J Hicks; Meredith A Bostrom; Jessica N Cooke; Caitrin W McDonough; Donald W Bowden
Journal:  PLoS Genet       Date:  2011-06-16       Impact factor: 5.917

10.  Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.

Authors:  Michael D Hughson; Victor G Puelles; Wendy E Hoy; Rebecca N Douglas-Denton; Susan A Mott; John F Bertram
Journal:  Nephrol Dial Transplant       Date:  2013-12-09       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.